Paper Title

COMPULSORY LICENSES IN THE PHARMACEUTICAL INDUSTRY DURING EPIDEMIC TIMES: A GLOBAL IMPERATIVE FOR PUBLIC HEALTH

Authors

Nerella Srinivas

Keywords

compulsory licenses (compulsory licenses)
intellectual property (ip)
pharmaceutical industry
public health
patents
trips agreement
public health emergencies
access to medicines
generic drugs
patent pooling
covid-19 pandemic
hiv/aids epidemic
trips waiver
government use licenses (guls)
global health governance.

Article Type

Research Article

Journal

INTERNATIONAL JOURNAL OF INTELLECTUAL PROPERTY RIGHTS

Issue

Volume : 10 | Issue : 2 | Page No : 21-33

Published On

December, 2019

Downloads

FULL PDF

CITATION

COPY LINK

Abstract

This paper critically evaluates the legal, ethical, and economic importance of compulsory licenses (Compulsory licenses) in the pharmaceutical sector during epidemic crises. Compulsory licenses have emerged as a potent instrument for improving access to life-saving vaccines and medications as the world battles infectious diseases such as COVID-19, Ebola, and HIV/AIDS. The paper examines the way in which compulsory licenses reconcile public health priorities with intellectual property (IP) rights by examining historical and contemporary case studies, thereby advocating for a reevaluation of global pharmaceutical governance. It urges the development of innovative solutions to guarantee equitable access to healthcare during future epidemics, based on evidence-based insights.